project id: TCGA-BRCA; case submitter id: TCGA-BH-A8FZ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.3; age at index: 58; days to birth: -21343; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1954; age at diagnosis: 21343; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 574.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8520/3; primary diagnosis: Lobular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 468; initial weight: 190.0; sample id: b8e8e280-c3ea-4757-bb41-1611c95dc868; sample submitter id: TCGA-BH-A8FZ-01A; portion id: 083f6892-19ab-475c-ac8e-cc611e1b59a0; portion submitter id: TCGA-BH-A8FZ-01A-11; slide id: 832c63ed-f000-4ec6-ad06-7ea7b1bb6a7c; slide submitter id: TCGA-BH-A8FZ-01A-01-TSA; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 5.0; percent stromal cells: 25.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; section location: TOP;